wl 19 has been researched along with exp3174 in 1 studies
| Studies (wl 19) | Trials (wl 19) | Recent Studies (post-2010) (wl 19) | Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) |
|---|---|---|---|---|---|
| 13 | 0 | 2 | 236 | 29 | 43 |
| Protein | Taxonomy | wl 19 (IC50) | exp3174 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0013 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0027 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0036 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.002 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0075 | |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0075 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakravarty, PK; Chang, RS; Greenlee, WJ; Lotti, VJ; Mantlo, NB; Ondeyka, DL; Patchett, AA; Siegl, PK; Sweet, CS | 1 |
1 other study(ies) available for wl 19 and exp3174
| Article | Year |
|---|---|
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Female; Imidazoles; Injections, Intravenous; Losartan; Macaca mulatta; Male; Pressoreceptors; Pyridines; Rats; Rats, Inbred Strains; Tetrazoles | 1992 |